Outlook Therapeutics

OTLK
Delayed Nasdaq - 02/24 10:00:00 pm
0.8999USD
-5.61%

OUTLOOK THERAPEUTICS, INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)

Envoyer par e-mail
02/14/2020 | 10:31 pm

Item 2.02 Results of Operations and Financial Condition



On February 14, 2020, Outlook Therapeutics, Inc. (the "Company") issued a press
release announcing its financial results for its first fiscal quarter ended
December 31, 2019. A copy of the press release is furnished as Exhibit 99.1 to
this Current Report on Form 8-K.



The information contained in this Item 2.02 and in the accompanying Exhibit 99.1
shall not be deemed filed for purposes of Section 18 of the Securities Exchange
Act of 1934, as amended, or incorporated by reference in any filing under the
Exchange Act or the Securities Act of 1933, as amended, except as shall be
expressly set forth by specific reference in such filing.



Item 9.01 Financial Statements and Exhibits



The information contained in Exhibit 99.1 shall not be deemed filed for the
purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or
incorporated by reference in any filing under the Exchange Act or the Securities
Act of 1933, as amended, except as shall be expressly set forth by specific
reference in such filing.






(d) Exhibits.




Exhibit No. Description



99.1 Press Release dated February 14, 2020.

© Edgar Online, source Glimpses

Acquiremedia 2020
Envoyer par e-mail